Moderate glycemic control safe in critically ill adult burn patients: A 15 year cohort study

Patricia Stoecklin1, Frederik Delodder1, Olivier Pantet1

  • 1Service of Intensive Care Medicine & Burns, University Hospital (CHUV), 1011 Lausanne, Switzerland.

Insights

Implementing a standardized intensive care unit (ICU) glucose control protocol in major burn patients improved glycemic control and reduced glucose variability. Moderate glucose management proved safe, significantly lowering hypoglycemia incidence while maintaining reduced hyperglycemia.

Area of Science:

  • Intensive Care Medicine
  • Burn Management
  • Metabolic Regulation

Background:

  • Hyperglycemia is a common complication in major burn patients, impacting outcomes.
  • Effective glucose control is crucial for managing metabolic alterations in severe burns.
  • Evaluating glucose control protocols in prolonged ICU stays for burn patients is essential.

Purpose of the Study:

  • To assess the safety and efficacy of general ICU glucose control protocols in major burn patients.
  • To analyze the impact of standardized protocols on glycemic control and variability.
  • To compare different phases of protocol implementation.

Main Methods:

  • Retrospective analysis of 229 adult burn patients over 15 years.
  • Inclusion criteria: adult burn patients with prolonged ICU treatment.
  • Exclusion criteria: death or length of stay <10 days, age <16 years.
  • Analysis of demographic, burn severity, infection, ICU stay, and outcome variables.
  • Metabolic variables included energy, carbohydrate, and insulin delivery, blood glucose, and CRP.
  • Data analyzed across four periods: pre-protocol, tight doctor-driven, tight nurse-driven, and moderate nurse-driven protocols.

Main Results:

  • The standardized protocol increased normoglycemic values from 34.7% to 65.9%.
  • Hypoglycemic events significantly reduced, with no extreme hypoglycemia in the final period.
  • Severe hyperglycemia persisted but decreased to 9.25% in the moderate control period.
  • Energy and glucose delivery decreased, while infectious complications increased in later periods.

Conclusions:

  • Standardized ICU glucose control protocols enhance glycemic management in adult burn patients.
  • Moderate glycemic control is safe, effectively reducing hypoglycemia incidence.
  • Protocols improve glucose variability, though persistent hyperglycemia requires continued attention.
Abstract

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
5.0K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.2K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.4K
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
1.1K
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
674